Compumedics Ltd (ASX: CMP) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Compumedics Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$78.91 million
P/E Ratio
45.71
Dividend Yield
0.00%
Shares Outstanding
199.76 million
Earnings per share
-0.007
Dividend per share
N/A
Year To Date Return
17.91%
Earnings Yield
2.19%
Franking
-
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Compumedics Ltd (ASX: CMP)
Latest News
Share Market News
Why this ASX healthcare share just downgraded its guidance
52-Week Highs
Why these ASX shares just surged to 52-week highs
Share Gainers
Compumedics share price rockets 26% higher on FDA news
Share Fallers
Why ARB, Compumedics, Coronado Global, Integrated Research are tumbling lower
Share Market News
Why the Compumedics share price is crashing 22% lower on Monday
Share Market News
3 results you might have missed on Thursday
Share Gainers
These 3 small cap shares are on the rise today
Share Fallers
Why these 4 ASX shares have started the week in the red
Share Fallers
Why the Compumedics Limited (ASX:CMP) share price has been smashed today
⏸️ Investing
These 3 small cap shares are on the rise today
⏸️ Investing
Why these small cap shares are racing higher today
⏸️ Investing
Why these 4 ASX shares jumped higher today
1❯
CMP ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Compumedics Ltd
Compumedics Ltd is a medical device company. It is engaged in the development, manufacturing, and commercialization of diagnostic technologies for sleep, brain, and ultrasonic blood-flow monitoring applications. The company is organized into geographical operating segments, being the United States of America, Australia and Asia Pacific, and Europe and the Middle East. It derives a majority of its revenue from Australia and the Asia Pacific region.
CMP Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 30 Jan 2026 | $0.40 | $-0.03 | -6.98% | 129,232 | $0.43 | $0.43 | $0.40 |
| 29 Jan 2026 | $0.43 | $0.00 | 0.00% | 27,574 | $0.44 | $0.44 | $0.42 |
| 28 Jan 2026 | $0.43 | $-0.02 | -4.44% | 62,502 | $0.45 | $0.45 | $0.42 |
| 27 Jan 2026 | $0.45 | $0.00 | 0.00% | 205,064 | $0.44 | $0.45 | $0.41 |
| 23 Jan 2026 | $0.45 | $0.09 | 24.66% | 695,750 | $0.37 | $0.45 | $0.37 |
| 22 Jan 2026 | $0.37 | $0.04 | 12.31% | 157,152 | $0.33 | $0.37 | $0.33 |
| 21 Jan 2026 | $0.33 | $0.00 | 0.00% | 5,179 | $0.33 | $0.33 | $0.33 |
| 20 Jan 2026 | $0.33 | $-0.01 | -3.03% | 4,000 | $0.33 | $0.33 | $0.33 |
| 19 Jan 2026 | $0.33 | $0.00 | 0.00% | 274 | $0.33 | $0.33 | $0.33 |
| 16 Jan 2026 | $0.33 | $0.00 | 0.00% | 56,211 | $0.33 | $0.34 | $0.33 |
| 15 Jan 2026 | $0.33 | $0.00 | 0.00% | 12,000 | $0.33 | $0.33 | $0.33 |
| 14 Jan 2026 | $0.34 | $-0.01 | -2.94% | 32,548 | $0.34 | $0.34 | $0.34 |
| 13 Jan 2026 | $0.34 | $0.00 | 0.00% | 51,247 | $0.34 | $0.35 | $0.34 |
| 12 Jan 2026 | $0.34 | $0.01 | 2.99% | 21,966 | $0.34 | $0.34 | $0.34 |
| 09 Jan 2026 | $0.34 | $-0.01 | -2.94% | 11,512 | $0.33 | $0.34 | $0.33 |
| 07 Jan 2026 | $0.34 | $0.00 | 0.00% | 39,207 | $0.35 | $0.35 | $0.34 |
| 06 Jan 2026 | $0.34 | $0.00 | 0.00% | 4,733 | $0.34 | $0.34 | $0.34 |
| 05 Jan 2026 | $0.34 | $0.00 | 0.00% | 144,149 | $0.35 | $0.36 | $0.33 |
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Dr David Burton | Chief Executive OfficerExecutive ChairmanExecutive Director | Nov 1987 |
Dr Burton is the founder and major shareholder through a related entity. His background includes the design and project management of Compumedics' first sleep laboratory and portable sleep systems. He has authored fifteen patents or patent applications that form part of Compumedics' key intellectual property. He has experience in the development, design, manufacture and sale of medical devices and in business development. He is also Chairman of the Board.
|
| Mr David Lawson | Chief Financial OfficerCompany SecretaryExecutive Director | Oct 2013 |
Mr Smith has experience in the development of the Compumedics business over the last 26 years and previously held several management positions with another listed public entity.
|
| Mr Rod James North | Non-Executive Director | Oct 2022 |
Mr North has over 30 years of experience in the financial and corporate sectors, having worked in share broking, investment and funds management, and in investor relations, media, and public relations for a range of ASX-listed companies over the past 19 years. He has experience in company analysis and financial management and has served on several investment committees in funds management. He has also acted in advisory roles to private and public companies at senior executive and board levels, focusing on capital raisings, communication, and investor relations strategies.
|
| Mr Christopher R Barys | Non-Executive Director | Sep 2025 |
Mr Barys is a U.S. MedTech executive with over 30 years of leadership at companies including Johnson & Johnson, Medtronic, Edwards Lifesciences, Philips Healthcare, and most recently as CEO of On Target Laboratories. His experience spans businesses, securing FDA approvals, driving strategic M&A, and building global commercial franchises.
|
| Warwick Freeman | Chief Technology Office |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| D & Dj Burton Holdings Pty Ltd | 96,002,819 | 49.94% |
| HSBC Custody Nominees (Australia) Limited | 11,569,649 | 6.02% |
| B & R James Investments Pty Limited | 5,000,000 | 2.60% |
| Beijing Bestmed Tech Ltd | 4,901,961 | 2.55% |
| Medigas Italia S R L | 4,333,333 | 2.25% |
| Mr David Francis Lawson & Ms Michelle Gabrielle Callinan | 2,464,482 | 1.28% |
| Electro Molecular Pty Ltd | 2,220,072 | 1.15% |
| Valui Pty Ltd | 1,920,987 | 1.00% |
| BNP Paribas Noms (Nz) Ltd | 1,606,224 | 0.84% |
| Ms Karin Jones | 1,489,492 | 0.77% |
| Mr Mark David Holder | 1,230,000 | 0.64% |
| Knowler Property Pty Ltd | 1,198,000 | 0.62% |
| Jarvsofaks Pty Ltd | 1,168,373 | 0.61% |
| Mr Bernard Frederick Knowler & Mrs Robynne Lynette Knowler | 1,120,000 | 0.58% |
| Avianto Pty Ltd | 1,079,975 | 0.56% |
| Mr Nigel Strong | 1,008,786 | 0.52% |
| Mr David Francis Lawson | 1,006,242 | 0.52% |
| P Morgan Nominees Australia Pty Limited | 913,989 | 0.48% |
| Bfa Super Pty Ltd | 778,188 | 0.40% |
| Cowan Grant Pty Ltd | 768,000 | 0.40% |
